Top Stories

Regeneron vows ‘vigorous’ defense against allegations it paid kickbacks for eye drug

Drugmaker Regeneron Pharmaceuticals has said it will “vigorously” defend against allegations by the Department of Justice that it paid kickbacks through a foundation in connection with a drug it markets for macular degeneration in order to cover Medicare beneficiaries’ copays. On Wednesday, the U.S. district attorney for Massachusetts filed suit against the Tarrytown, New York-based […]